Monday, October 26, 2026 · Daily editionET --:--:--

By invitation only

Robotic Exoskeleton Assisted Gait Post Stroke

NCT04309305 · Kessler Foundation · Updated 6 April 2025

What is being tested
EksoGT™, Ekso Bionics, Berkley, CA, USA; Standard of Care; No Intervention
For
CVA; Gait, Hemiplegic
Kind of study
Tests a treatment or device on volunteers. Phase 1.
Who can join
Ages 21 years to 80 years. About 75 people. The full rules are on the registry page.
Where
United States
When
Starts or started 30 Jan 2020, ends 1 Sept 2026. Registered 16 March 2020.
Results
None posted yet.

In the researchers' words

The current investigation takes advantage of both a progressive and adaptive assist-as-needed massed practice and time-sensitive neuroplasticity through exoskeleton assisted walking in order to induce greater recovery-oriented CNS plasticity and consequent gains in more independent walking.
ClinicalTrials.gov, NCT04309305

Sites

  • Kessler FoundationWest Orange, New Jersey, United States